Comparing intensive outpatient monitoring for stroke and heart attack patients to usual monitoring
Medical-economic Evaluation Comparing Intensive Outpatient Monitoring of Neuro-cardiovascular Diseases by Nurses, Doctors and Hospital and Private-sector Pharmacists, Compared to Usual Monitoring.
This study is testing if more careful outpatient monitoring can help stroke and heart attack patients manage their health better than regular monitoring.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1720 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire Dijon Academic / other |
| Locations | 1 site (Dijon) |
| Trial ID | NCT04188457 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the effectiveness of intensive outpatient monitoring for patients with cerebrovascular accidents and myocardial infarctions, comparing it to standard monitoring practices. The study aims to address the common risk factors associated with these conditions, such as hypertension and diabetes, which remain inadequately controlled. By involving nurses, doctors, and pharmacists in the monitoring process, the study seeks to improve patient outcomes and reduce chronic disabilities following these events. Participants will be followed in specific health establishments to assess the impact of intensive monitoring on their health.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 years old who have experienced a primary or recurrent myocardial infarction or stroke and are expected to survive beyond 12 months.
Not a fit: Patients who are not affiliated with the national health insurance system or those under legal protection may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to better management of stroke and heart attack patients, potentially reducing long-term disabilities and improving survival rates.
How similar studies have performed: Other studies have shown promising results with intensive monitoring approaches for similar conditions, indicating potential for success in this study.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient or legal representative who has given oral consent * Patient over 18 years of age * Patient with: * either a primary MI or a recurrent MI, not previously included, defined according to the criteria of the European Society of Cardiology and ICD-10 * either a primary stroke, a recurrent stroke not previously included, hemorrhagic, ischemic or Transient Ischemic Attack (TIA), defined according to WHO criteria, the TOAST score and the ICD-10, with a Rankin score \< 5. * Patient followed up in one of the 6 public health establishments of the GHT 21-52 (regional group of hospitals) or at the Valmy clinic in Dijon also participating in the project * Patient with estimated survival beyond 12 months Exclusion Criteria: * A patient who is not affiliated to the national health insurance system; * A patient subject to legal protection (curatorship, guardianship) * To be a patient subject to a measure of judicial safeguard; * Pregnant, parturient or breastfeeding woman; * Admitted for a condition other than stroke, TIA and MI; * Experiencing heart failure before the MI; * Be managed in EHPAD before and/or after stroke or IDM.
Where this trial is running
Dijon
- Chu Dijon Bourgogne — Dijon, France (Recruiting)
Study contacts
- Study coordinator: Yannick BEJOT
- Email: yannick.bejot@chu-dijon.fr
- Phone: 03.80.29.37.53
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.